http://www.ablynx.com/
anyone who knows something about this future biotech multi-bagger? (current price targets up to 70% above today's price)
listed on Euronext Brussels and relatively new on Nasdaq (successfull IPO last month, they raised 175 million dollar)
first drug candidate was approved + very promising pipeline.
"Ablynx is a Belgian biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments.
Today, the Company has approximately 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease."